AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AVAH • US05356F1057

7.84 USD
-0.62 (-7.33%)
At close: Feb 4, 2026
7.89 USD
+0.05 (+0.64%)
After Hours: 2/4/2026, 8:04:23 PM
Fundamental Rating

5

AVAH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. AVAH has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on AVAH.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • AVAH had positive earnings in the past year.
  • In the past year AVAH had a positive cash flow from operations.
  • In the past 5 years AVAH always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: AVAH reported negative operating cash flow in multiple years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • AVAH has a better Return On Assets (4.17%) than 71.57% of its industry peers.
  • AVAH's Return On Equity of 761.17% is amongst the best of the industry. AVAH outperforms 100.00% of its industry peers.
  • AVAH has a better Return On Invested Capital (13.25%) than 90.20% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AVAH is below the industry average of 9.16%.
  • The 3 year average ROIC (5.94%) for AVAH is below the current ROIC(13.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROIC 13.25%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • The Profit Margin of AVAH (3.29%) is better than 71.57% of its industry peers.
  • AVAH has a better Operating Margin (10.25%) than 80.39% of its industry peers.
  • AVAH's Operating Margin has improved in the last couple of years.
  • AVAH has a Gross Margin of 33.57%. This is in the better half of the industry: AVAH outperforms 65.69% of its industry peers.
  • AVAH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • AVAH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, AVAH has more shares outstanding
  • AVAH has more shares outstanding than it did 5 years ago.
  • AVAH has a better debt/assets ratio than last year.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • AVAH has an Altman-Z score of 1.27. This is a bad value and indicates that AVAH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AVAH (1.27) is worse than 62.75% of its industry peers.
  • AVAH has a debt to FCF ratio of 17.78. This is a negative value and a sign of low solvency as AVAH would need 17.78 years to pay back of all of its debts.
  • AVAH has a Debt to FCF ratio of 17.78. This is comparable to the rest of the industry: AVAH outperforms 42.16% of its industry peers.
  • AVAH has a Debt/Equity ratio of 130.05. This is a high value indicating a heavy dependency on external financing.
  • AVAH has a worse Debt to Equity ratio (130.05) than 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Altman-Z 1.27
ROIC/WACC1.28
WACC10.35%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that AVAH should not have too much problems paying its short term obligations.
  • AVAH has a Current ratio (1.23) which is comparable to the rest of the industry.
  • AVAH has a Quick Ratio of 1.23. This is a normal value and indicates that AVAH is financially healthy and should not expect problems in meeting its short term obligations.
  • AVAH has a Quick ratio (1.23) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • AVAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2500.00%, which is quite impressive.
  • Measured over the past years, AVAH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -49.58% on average per year.
  • Looking at the last year, AVAH shows a quite strong growth in Revenue. The Revenue has grown by 15.48% in the last year.
  • AVAH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 142.61% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AVAH will show a quite strong growth in Revenue. The Revenue will grow by 10.48% on average per year.
EPS Next Y1058.72%
EPS Next 2Y253.29%
EPS Next 3Y142.61%
EPS Next 5YN/A
Revenue Next Year20.45%
Revenue Next 2Y13.02%
Revenue Next 3Y10.48%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.33, which indicates a correct valuation of AVAH.
  • Based on the Price/Earnings ratio, AVAH is valued cheaply inside the industry as 80.39% of the companies are valued more expensively.
  • AVAH is valuated rather cheaply when we compare the Price/Earnings ratio to 28.25, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 12.56, AVAH is valued correctly.
  • Based on the Price/Forward Earnings ratio, AVAH is valued cheaper than 84.31% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. AVAH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.33
Fwd PE 12.56
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AVAH is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
  • 66.67% of the companies in the same industry are more expensive than AVAH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.85
EV/EBITDA 12.9
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • AVAH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AVAH has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as AVAH's earnings are expected to grow with 142.61% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y253.29%
EPS Next 3Y142.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AVAH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (2/4/2026, 8:04:23 PM)

After market: 7.89 +0.05 (+0.64%)

7.84

-0.62 (-7.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-11
Inst Owners23.38%
Inst Owner Change1.01%
Ins Owners5.67%
Ins Owner Change-2.23%
Market Cap1.64B
Revenue(TTM)2.29B
Net Income(TTM)75.46M
Analysts77.65
Price Target10.94 (39.54%)
Short Float %8.47%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)232.09%
Min EPS beat(2)51.78%
Max EPS beat(2)412.4%
EPS beat(4)4
Avg EPS beat(4)2370.21%
Min EPS beat(4)51.78%
Max EPS beat(4)6955.89%
EPS beat(8)8
Avg EPS beat(8)1242.78%
EPS beat(12)10
Avg EPS beat(12)826.72%
EPS beat(16)10
Avg EPS beat(16)602.5%
Revenue beat(2)2
Avg Revenue beat(2)5.46%
Min Revenue beat(2)2.96%
Max Revenue beat(2)7.96%
Revenue beat(4)4
Avg Revenue beat(4)4.95%
Min Revenue beat(4)2.02%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.57%
Revenue beat(12)10
Avg Revenue beat(12)2.07%
Revenue beat(16)11
Avg Revenue beat(16)0.9%
PT rev (1m)0%
PT rev (3m)7.9%
EPS NQ rev (1m)19.61%
EPS NQ rev (3m)48.57%
EPS NY rev (1m)4.75%
EPS NY rev (3m)29.81%
Revenue NQ rev (1m)4.15%
Revenue NQ rev (3m)8.55%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)4.5%
Valuation
Industry RankSector Rank
PE 16.33
Fwd PE 12.56
P/S 0.72
P/FCF 19.85
P/OCF 18.29
P/B 165.21
P/tB N/A
EV/EBITDA 12.9
EPS(TTM)0.48
EY6.12%
EPS(NY)0.62
Fwd EY7.96%
FCF(TTM)0.39
FCFY5.04%
OCF(TTM)0.43
OCFY5.47%
SpS10.96
BVpS0.05
TBVpS-5.75
PEG (NY)0.02
PEG (5Y)N/A
Graham Number0.72
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROCE 16.77%
ROIC 13.25%
ROICexc 14.79%
ROICexgc 415.4%
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
FCFM 3.6%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexgc growth 3Y3.46%
ROICexgc growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Debt/EBITDA 5.62
Cap/Depr -130.77%
Cap/Sales 0.31%
Interest Coverage 1.56
Cash Conversion 39.02%
Profit Quality 109.35%
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1.27
F-Score8
WACC10.35%
ROIC/WACC1.28
Cap/Depr(3y)53.12%
Cap/Depr(5y)65.29%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
EPS Next Y1058.72%
EPS Next 2Y253.29%
EPS Next 3Y142.61%
EPS Next 5YN/A
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%
Revenue Next Year20.45%
Revenue Next 2Y13.02%
Revenue Next 3Y10.48%
Revenue Next 5YN/A
EBIT growth 1Y90.23%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year111.52%
EBIT Next 3Y31.81%
EBIT Next 5YN/A
FCF growth 1Y469.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y715.42%
OCF growth 3YN/A
OCF growth 5YN/A

AVEANNA HEALTHCARE HOLDINGS / AVAH FAQ

What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AVAH.


What is the valuation status for AVAH stock?

ChartMill assigns a valuation rating of 7 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Undervalued.


How profitable is AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 6 / 10.


What is the valuation of AVEANNA HEALTHCARE HOLDINGS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 16.33 and the Price/Book (PB) ratio is 165.21.


Can you provide the expected EPS growth for AVAH stock?

The Earnings per Share (EPS) of AVEANNA HEALTHCARE HOLDINGS (AVAH) is expected to grow by 1058.72% in the next year.